PRESENTATION
Q1 2022 — Earnings presentation
Q1 2022PDF · 26 pages13.9 MB
Delivering a Smoke-Free Future
2022 First-Quarter Results
April 21, 2022
Introduction
• A glossary of key terms and definitions, including the definition for reduced-risk products, or
"RRPs," additional heated tobacco unit market data, as well as adjustments, other calculations and
reconciliations to the most directly comparable U.S. GAAP measures are at the end of today’s
webcast slides, which are posted on our website
• Unless otherwise stated, all references to IQOS are to our IQOS heat-not-burn products, and all
references to smoke-free products refer to RRPs
• Growth rates presented on an organic basis reflect currency-neutral adjusted results, excluding
acquisitions
• Figures and comparisons presented on a pro forma basis entirely exclude PMI’s operations in
Russia and Ukraine
• In the third quarter of 2021, we acquired Fertin Pharma A/S, Vectura Group plc. and OtiTopic, Inc.
On March 31, 2022, we launched a new Wellness and Healthcare business Vectura Fertin Pharma,
which consolidates these entities. The operating results of this new business are reported in the
‘Other’ category. Business operations of our Wellness and Healthcare business are managed and
evaluated separately from the geographical segments
2
-- 1 of 26 --
Forward-Looking and Cautionary Statements
• This presentation and related discussion contains projections of future results and other forward-looking statements. Achievement of future results is subject to risks,
uncertainties and inaccurate assumptions. In the event that risks or uncertainties materialize, or underlying assumptions prove inaccurate, actual results could vary
materially from those contained in such forward-looking statements. Pursuant to the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, PMI is
identifying important factors that, individually or in the aggregate, could cause actual results and outcomes to differ materially from those contained in any forward-looking
statements made by PMI
• PMI's business risks include: excise tax increases and discriminatory tax structures; increasing marketing and regulatory restrictions that could reduce our competitiveness,
eliminate our ability to communicate with adult consumers, or ban certain of our products in certain markets or countries; health concerns relating to the use of tobacco and
other nicotine-containing products and exposure to environmental tobacco smoke; litigation related to tobacco use and intellectual property; intense competition; the
effects of global and individual country economic, regulatory and political developments, natural disasters and conflicts; the impact and consequences of Russia's invasion of
Ukraine; changes in adult smoker behavior; lost revenues as a result of counterfeiting, contraband and cross-border purchases; governmental investigations; unfavorable
currency exchange rates and currency devaluations, and limitations on the ability to repatriate funds; adverse changes in applicable corporate tax laws; adverse changes in
the cost, availability, and quality of tobacco and other agricultural products and raw materials, as well as components and materials for our electronic devices; and the
integrity of its information systems and effectiveness of its data privacy policies. PMI's future profitability may also be adversely affected should it be unsuccessful in its
attempts to produce and commercialize reduced-risk products or if regulation or taxation do not differentiate between such products and cigarettes; if it is unable to
successfully introduce new products, promote brand equity, enter new markets or improve its margins through increased prices and productivity gains; if it is unable to
expand its brand portfolio internally or through acquisitions and the development of strategic business relationships; or if it is unable to attract and retain the best global
talent, including women or diverse candidates. Future results are also subject to the lower predictability of our reduced risk product category's performance
• In addition, PMI’s business risks also include risks and uncertainties related to PMI’s acquisitions of Fertin Pharma A/S ("Fertin"), OtiTopic, Inc. ("OtiTopic") and Vectura
Group plc ("Vectura"), including, amongst other things: (1) the possibility that the integration of the operations of Fertin and Vectura with those of PMI may be more difficult
and/or take longer than anticipated, and may not accelerate PMI’s desired entry into additional smoke-free and beyond nicotine platforms as quickly as anticipated; (2) the
possibility that the respective integrations of Fertin and Vectura into PMI may be more costly than anticipated and may have unanticipated adverse results relating to
Fertin, Vectura or PMI’s existing businesses; (3) the inability to gain access to or acquire differentiated proprietary assets, technology and/or pharmaceutical development
expertise as anticipated by these acquisitions; (4) risks associated with third-party contracts containing consent and/or other contractual provisions that may be triggered
by the acquisitions; (5) the success of the research and development efforts of Fertin, OtiTopic and Vectura, including the ability to obtain regulatory approval for new
products, and the ability to commercialize or license these new products; (6) any unanticipated safety, quality or efficacy concerns and the impact of identified concerns
associated with the products developed by Fertin, OtiTopic and Vectura; and (7) the ability of PMI to retain key personnel of Fertin and Vectura, or hire key talent to work in
the Fertin and Vectura businesses due to their affiliation with PMI
• PMI is further subject to other risks detailed from time to time in its publicly filed documents, including the Form 10-K for the year ended December 31, 2021. PMI cautions
that the foregoing list of important factors is not a complete discussion of all potential risks and uncertainties. PMI does not undertake to update any forward-looking
statement that we may make from time to time, except in the normal course of its public disclosure obligations
3
Focus on Supporting Our Employees Impacted by the Crisis in
Ukraine
• Evacuated over 1,000 people
(employees and their families) from the
country and supported more than 2,700
others to move from conflict zones
• Delivering critical aid to those that
remain in Ukraine
• Providing accommodation, assistance
and support for a path forward for those
who leave the country
• Contributed around $10m in funds and
donated essential items to humanitarian
efforts, further ~$25m in estimated
costs for additional employee support
4
-- 2 of 26 --
Actively Working to Address Impact of War in Ukraine
Strong Business Outlook Excluding Russia and Ukraine
• Ukraine manufacturing suspended at Kharkiv
facility
• Business activities most impacted in eastern
Ukraine, some resumption in areas where
conditions allow as we seek to maximize product
availability for consumers, using inventories on
hand
• Supporting all our Ukrainian employees:
⎼ Continuing to pay salaries
⎼ Substantial in-kind support to employees and their
families
• Providing additional humanitarian aid
5
• PMI Board and senior executives working on
options to exit the Russian market in an orderly
manner, in context of complex and rapidly changing
regulatory and operating environment
• Concrete steps already taken to scale back
operations:
⎼ All new investments and product launches cancelled,
including IQOS ILUMA and IQOS VEEV
⎼ Delisting 25% of cigarette products, including Marlboro
and Parliament SKUs
⎼ Canceled $150m investment to ultimately
manufacture >20bn TEREA sticks in Russian facility
• Supporting our 3,200 employees, continuing to pay
salaries and fulfilling our legal obligations
Ukraine Russia
Source: PMI Financials or estimates
Very Strong Q1 Performance, Robust Year Ahead
• Excellent Q1 2022 organic net revenue and EPS growth
• Very strong quarter for IQOS user acquisition as device supply
constraints ease:
⎼ >1 million user growth excl. Russia & Ukraine
⎼ 23% RRP pro forma organic net revenue growth
⎼ Pro forma smoke-free net revenues over 30% of total PMI
• PMI HTUs now the second largest nicotine brand in markets
where IQOS is present, excl. Russia & Ukraine
• IQOS ILUMA superb start continues in Japan, Switzerland &
Spain
• Volume and net revenue growth in combustibles with growing
category share
• Strong start on a year of robust expected organic growth
Source: PMI Financials or estimates 6
-- 3 of 26 --
(a) Reflects total PMI net revenues divided by total PMI cigarette and HTU shipment volume
Source: PMI Financials or estimates 7
Q1, 2022: Strong Start to the Year
Adjusted Diluted EPS
(Currency neutral variance vs. PY) +14.0 %
OI Margin
(Organic variance vs. PY) (30) bps
Net Revenue per Unit(a)
(Organic variance vs. PY) +5.3 %
Net Revenues
(Organic variance vs. PY) +9.0 %
Total PMI Pro Forma
+16.0 %
(40) bps
+4.9 %
+10.0 %
(a) On an organic basis
(b) On a currency-neutral basis
Source: PMI Financials or estimates
Positive 2022 Outlook
• Strong growth fundamentals
intact
• Now expect 2022 pro forma
adjusted diluted EPS of $5.35-
$5.46, including an unfavorable
currency impact of 63 cents at
prevailing exchange rates
8
FY 2022
Previous Outlook
For Full Year
(February 10th )
Pro forma Outlook
Ex-Russia & Ukraine
For Full Year
(April 21st)
Net Revenue
Growth(a) 4-6 % 4.5-6.5 %
Adjusted OI Margin
Expansion(a) 50-150bps 0-100 bps
Adjusted Diluted
EPS Growth(b) 8-11 % 9-11 %
Adjusted Diluted
EPS $6.12-$6.30 $5.35-$5.46
-- 4 of 26 --
Source: PMI Financials or estimates
Strong HTU Volume Growth Outlook
9
Previous Outlook
For Full Year
(February 10th )
Pro forma Outlook
Ex-Russia &
Ukraine
For Full Year
(April 21st)
Q1’22 Actuals
Russia & Ukraine
Pro Forma Outlook
+ Q1’22 Actuals
Russia & Ukraine
Combined
HTU Shipment
Volume
(in billion units)
113-118 88-92 ~5 93-97
HTU Shipment
Volume Growth
19-24 %
(vs. 2021 total
95.0 billion units)
20-25 %
(vs. 2021 pro forma
73.5 billion units)
2022 Key Assumptions
10
(a) Pro forma basis excluding Russia and Ukraine
(b) Excluding Russia, Ukraine, China and the U.S. Includes Cigarettes and HTUs
Note: Operating cash flow is defined as net cash provided by operating activities
Source: PMI Financials or estimates
2022
Forecast Assumptions
Total Industry Volume(a)(b) -1% to stable
PMI Total Shipment Volume(a) stable to +1%
Effective Tax Rate 21-22%
Operating Cash Flow ~$10bn
Capital Expenditures ~$1.0bn
-- 5 of 26 --
Expect Robust H1 With Profit Accelerating in H2
11
• Q2 expected to be impacted by temporary / specific
factors:
⎼ Higher device volumes and stepped-up channel replenishment
for reaccelerating IQOS user acquisition
⎼ Corresponding catch-up on commercial investment
⎼ Timing of HTU and cigarette shipments to Japan
⎼ Turkey hyperinflation, with challenging exchange rate
comparison
⎼ Additional air freight costs
• Robust overall H1 expected
• Adjusted pro forma OI margin expansion and EPS
growth H2-weighted
2022 Pro Forma(a)
H1 Full Year
Net Revenue
Growth Organic 5-7 % 4.5-6.5 %
Adjusted
Diluted EPS
$2.65-
$2.70 (b)
$5.35-
$5.46
Source: PMI Financials or estimates
(a) Pro forma basis excluding Russia and Ukraine
(b) H1 2021 pro forma adjusted diluted EPS was $2.86
Continued Strong Mid-Term Outlook
• Strong 2022 outlook places us firmly on
track to deliver mid-term targets on pro
forma basis:
⎼ 2021-23 CAGRs of >5% organic net revenues,
>9% currency-neutral adjusted diluted EPS
⎼ Around $2 billion in gross cost savings
• Continue to aim for >50% of net revenues to
be smoke-free by 2025
Source: PMI Financials or estimates 12
-- 6 of 26 --
Note: Total might not foot due to roundings
Source: PMI Financials or estimates 13
Total PMI Shipment Volume: Excellent Growth
(billion units)
145.5 148.2
21.7 24.8
167.2 173.1
Q1, 2021 Q1, 2022
HTUs
Cigarettes
Total
+14.2%
+1.9%
+3.5%
Change
vs. PY
131.1 135.3
17.0 20.1
148.0 155.3
Q1, 2021 Q1, 2022
HTUs
Cigarettes
Total
+18.4%
+3.2%
+4.9%
Change
vs. PY
Pro Forma Total PMI
Rapid Smoke-Free Transformation Continues
14
(a) Total volume includes HTUs and cigarettes
(b) Smoke-free net revenues include RRP net revenues and net revenues from the ‘Other’ category
Source: PMI Financials or estimates
11.6%
12.9%
2021 Q1, 2022
PMI HTU Shipment Volume (billion units)
73.5 20.1
Pro Forma HTU Volume Contribution (a)
(As a % of PMI Total Shipment Volume)
27.9%
30.4%
2021 Q1, 2022
Smoke-Free Net Revenues ($ in billion)
$8.1 $2.2
Pro Forma Smoke-Free Net Revenues(b)
(Smoke-Free Net Revenues as a % of
Total PMI Adjusted Net Revenues)
-- 7 of 26 --
15 Source: PMI Financials or estimates
Volume Growth & Twin Engines Powering Organic Net Revenues
+2.1pp
Q1, 2022
Shipment Volume
Increase
Organic Net
Revenue Growth
Q1, 2022
Net Revenue
Growth
+3.5%
Category Mix & Other,
including Device
Impact
Combustible and
HTU pricing
+10.0%
Currency &
Acquisitions
+4.9%
Pro Forma
+3.0pp
(6.5)pp
16 Source: PMI Financials or estimates
Temporary COGS Headwinds Impacting OI Margin
+2.1pp (2.5)pp (2.7)pp
Q1, 2021 Q1, 2022
(excluding currency & acquisition)
Q1, 2022
SG&A & Other Gross Margin
+46.1%
Currency &
Acquisitions
+46.5%
+43.4%
Pro Forma Adjusted OI Margin
-- 8 of 26 --
Robust Combustible Trends Support Smoke-Free Future
• Volume recovery notably driven by
Indonesia, Philippines, Spain and Duty Free
• PMI portfolio performing well with growing
category share
• Continue to target stable share of declining
cigarette category over time to maximize
switching to smoke-free products
17
Note: Excluding Russia, Ukraine, China and the U.S. Reflects sales volume of PMI cigarettes as a percentage of cigarette industry sales volume
Source: PMI Financials or estimates
Pro Forma Share of Cigarette Category
(Change vs. PY in pp)
(1.2) (1.0)
(0.5)
-
0.4
Q1’21 Q2’21 Q3’21
Q4’21
Share of Category (in %)
24.0 24.6 25.1 24.8 24.4
Q1’22
—
Positive Total Market Share Momentum
18
(a) Reflects 66 markets where IQOS HTUs are available in key cities or nationwide at March 31, 2022. Excludes Russia, Ukraine and the U.S.
Note: Reflects sales volume as a percentage of the total industry sales volume for cigarettes and HTUs. Excluding Russia, Ukraine, China and the U.S. All ‘brands’ except ‘PMI HTUs’ include
cigarettes only
Source: PMI Financials or estimates
Pro Forma International Share
(Change vs. PY in pp)
(0.8) (0.7)
(0.2)
0.2
0.7
Q1’21 Q2’21 Q3’21
Q4’21
Q1’22 International Nicotine Brand
Share in IQOS Markets(a)
14.5%
4.9%
3.5%
Marlboro L&M Chesterfield PMI HTUs Winston
#2
7.5%
Q1’22
Pall Mall
-- 9 of 26 --
(a) See Glossary for definition
Note: Russia and Ukraine not included in total users for Q1, 2022
Source: PMI Financials or estimates, IQOS user panels and PMI Market Research
Strong IQOS User Growth Recovery
19
Total IQOS Users(a)
15.0 15.8 15.9 16.8 17.9
Q1 Q2 Q3 Q4 Q1
2021 2022
71% 71% 71% 71% 71%
19.5 20.5 20.7 21.7
Total Users
Russia & Ukraine
PMI ex-Russia & Ukraine
Estimated users who
have switched to IQOS
and stopped smoking(a)
Q1 Q2 Q3 Q4 Q1
5.4 5.9 6.4 6.8
7.4
EU Region: Strong Underlying HTU Growth
(a) Based on a four-quarter moving average
Note: Market share for HTUs is defined as the total sales volume for HTUs as a percentage of the total
estimated sales volume for cigarettes and HTUs
Source: PMI Financials or estimates
5.5% 5.3%
6.4%
5.6%
2021 2022
HTU SoM IMS (a)
(in billion units)
20
7.6%
-- 10 of 26 --
Accelerating Key City Shares in Europe
21
(a) Athens represents Attica Region
Source: PMI Financials or estimates
3.2% 5.0% 6.4% 9.1% 10.8% 11.2%
15.8% 17.2% 17.9% 19.5%
24.1% 24.2%
28.7%
38.3%
Madrid Vienna London Munich Bucharest Zurich Warsaw Lisbon Milan Prague Rome Athens Budapest Vilnius
+1.5pp +1.1pp +2.7pp +4.0pp +4.1pp
PMI HTU Offtake Shares (Q1, 2022)
+1.0pp
Change vs. PY
+1.0pp +2.9pp +2.7pp +1.9pp +2.5pp +2.5pp +5.3pp
(a)
+7.0pp
Q1 Q2 Q3 Q4 Q1 Q2 Est.
7.5
7.7
7.9 8.0 8.1
Japan: Continued IQOS HTU Growth
(a) Adjusted market share for HTUs is defined as the total sales volume for HTUs as a percentage of the total estimated
sales volume for cigarettes, HTUs and cigarillos and excluding the impact of estimated trade inventory movements
(b) Based on a four-quarter moving average
Source: PMI Financials or estimates
20.8%
21.8%
2021 2022
HTU Adjusted SoM(a) IMS (b)
(in billion units)
22
22.7%
Sendai
+1.5pp
27.3%
25.8%
Q1’21 Q1’22
Change vs. PY
Tokyo 28.4%
26.1%
+2.3pp
~24%
Fukuoka 24.7%
22.6%
+2.1pp
21.0% 20.8%
-- 11 of 26 --
1.4
1.6 1.7
1.9
2.1
Encouraging Progress in Low and Middle-Income Markets
(a) Based on a four-quarter moving average
Note: 28 Low & Middle-Income markets where PMI commercialized IQOS at 31 December 2021, excluding Duty Free, Russia and Ukraine. Low &
Middle-Income markets defined using World Bank classification where available. Palestine is included as a Low & Middle-Income market
Source: PMI Financials or estimates 23
Q1 Q2 Q3 Q4 Q1
2.0% 1.9%
2.2%
1.8%
2021 2022
HTU SoM IMS (a)
(in billion units) 2.6%
(a) Amman represents West Amman
Source: PMI Financials or estimates
Promising IQOS Growth in Low & Middle-Income Markets
(PMI HTU offtake share in Key Cities)
24
Amman(a)
Beirut
Belgrade
Urban Cairo
Cape Town
Casablanca
Kuala Lumpur
Metro Manila
San Jose
Santo Domingo
Tbilisi
+2.7pp
6.3%
9.0%
+5.3pp
+4.3pp
+0.4pp
+1.3pp
+1.6pp
+0.3p +3.8pp
13.1%
7.8%
4.3%
2.3%
1.9%
1.3%
13.9%
12.3%
1.3%
1.0%
12.0%
8.9%
+1.9pp
7.1%
9.0% 2.6%
0.9%
7.0%
5.8%
+1.2pp
Q1’21 Q1’22 Q1’21 Q1’22 Q1’21 Q1’22 Q1’21 Q1’22
Change vs. PY
Skopje 10.6%
6.8%
+1.7pp +3.1pp
-- 12 of 26 --
Superb Results of IQOS ILUMA in Japan
• Over 20% of ILUMA users are new
users, and over 30% of total IQOS users
now using ILUMA
• Higher conversion rates
• TEREA the fastest-growing launch in the
smoke-free category with 12% offtake
share in 6 months, overtaking IQOS
blade consumables
• ILUMA ONE launched in March
• SENTIA HTUs launching in April in
select prefectures at mainline price
25
(a) Based on 3 C-Store Chains offtake. Base includes cigarettes, cigarillos and RRP
Note: New users are former Legal Age Smokers or Legal Age Nicotine Users
Source: PMI Financials or estimates
Japan Offtake Share (a)
0%
5%
10%
15%
20%
25%
Marlboro
Heatsticks
(7.3%)
TEREA
(12.1%)
HEETS
(4.1%)
Total PMI
HTU (24.0%)
Jul
Aug
Sep
Oct
Nov
Dec
Jan
Feb
Mar
2021 2022
Positive Start for IQOS ILUMA in Switzerland & Spain
• Switzerland exhibiting similar or better early
trends since early November launch
• Accelerated smoker acquisition and upgrades
from existing users
• TEREA now approaching 2/3 PMI HTU sales
26
Switzerland
Spain
• Over 10% of existing users upgraded in first
month
• 50% increase in IQOS device sales to new users
• TEREA offtake exiting March at ¼ of HTU sales
• Significant increase in Net Promoter Score
5.5% 5.7% 5.8%
7.4%
9.0%
Q1 Q2 Q3 Q4 Q1
4%
Switzerland HTU SoM
2021 2022
Source: PMI Financials or estimates
-- 13 of 26 --
Launch Plans for ILUMA and Other HnB Innovations
• Strong potential confirmed in Japan,
Switzerland and Spain
• Timing of HTU supply for new markets
impacted by outstanding success in first
markets and disruption from canceled
investment in Russia
• Further market launches now mostly
expected towards end of H2
• Rich pipeline of innovations and portfolio
expansion on devices and HTUs across
HnB technologies
27
IQOS VEEV: Strong Progress
• Strong progress following
distribution and consumable
range expansions
• Achieved despite average device
price premium of 20-30%
• Further market roll-outs planned
this year
• Present in 7 markets
(a) Source: Nielsen, Indirect retail only
(b) Source: Key Account sales
Note: IMS share data based on ml
Source: PMI Financials or estimates
VEEV Offtake Share
(Closed System Pods, in %)
Croatia(b) Czech
Republic(b) Italy (a)
2.5 2.6
6.0
13.9
19.8
0%
5%
10%
15%
20%
Q1 Q2 Q3 Q4 Q1
4.8
6.6
8.5
10.7
9.6
0%
3%
6%
9%
Q1 Q2 Q3 Q4 Q1
1.3
5.1
6.5
0%
2%
4%
6%
Q1 Q2 Q3 Q4 Q1
2021 2022 2021 2022 2021 2022
28
-- 14 of 26 --
Sustainability at the Core of Our Strategy
Enhancing approach to sustainability:
• Updated statement of purpose recognizing role of
wellness and healthcare in our transformation
• Reassessed ESG priorities and published dedicated
Sustainability Materiality report, introducing new ESG
framework
• Sustainability Index introduced in Proxy statement,
explicitly linking ESG performance to long-term executive
compensation
• 2021 Integrated Report to be published on May 17, 2022
Product health impact:
• Growing penetration of smoke-free products to
accelerate the end of smoking
• Continued positive regulatory developments recognizing
harm reduction credentials of smoke-free products
29
Strong Growth Fundamentals for 2022 and Beyond
• Excellent start to 2022
• Exceptional initial results from ILUMA
• Rich pipeline of innovation across smoke-free
categories
• Robust recovery in combustible performance
supports smoke-free transformation
• Investing in long-term growth in wellness and
healthcare
• 2022 pro forma fundamentals remain strong:
⎼ Rapid top-line growth outlook driven by IQOS
⎼ Expecting margin expansion despite inflation
and supply chain disruption
• Confident in mid-term growth outlook
30 Source: PMI Financials or estimates
-- 15 of 26 --
Delivering a Smoke-Free Future
2022 First-Quarter Results
Questions & Answers
iOS Download Android Download Have you downloaded the PMI Investor Relations App?
The free IR App is available to download at the Apple App Store
for iOS devices and at Google Play for Android mobile devices
Or go to: www.pmi.com/irapp
Delivering a Smoke-Free Future
2022 First-Quarter Results
April 21, 2022
-- 16 of 26 --
33
Glossary of Key Terms and Definitions,
Appendix, and
Reconciliation of Non-GAAP Measures
Glossary: General Terms
• "PMI" refers to Philip Morris International Inc. and its subsidiaries. Trademarks and service marks that are the registered property of, or
licensed by, the subsidiaries of PMI, are italicized
• Until March 28, 2008, PMI was a wholly owned subsidiary of Altria Group, Inc. ("Altria"). Since that time the company has been independent and
is listed on the New York Stock Exchange (ticker symbol "PM")
• Comparisons are made to the same prior-year period unless otherwise stated
• Unless otherwise stated, references to total industry, total market, PMI shipment volume and PMI market share performance reflect cigarettes
and heated tobacco units
• References to total international market, defined as worldwide cigarette and heated tobacco unit volume excluding the U.S., total industry, total
market and market shares are PMI estimates for tax-paid products based on the latest available data from a number of internal and external
sources and may, in defined instances, exclude the People's Republic of China and/or PMI's duty free business
• 2021 and 2022 estimates for total industry volume and market share in certain geographies reflect limitations on the availability and accuracy
of industry data during pandemic-related restrictions
• "OTP" is defined as "other tobacco products," primarily roll-your-own and make-your-own cigarettes, pipe tobacco, cigars and cigarillos, and
does not include reduced-risk products
• "Combustible products" is the term PMI uses to refer to cigarettes and OTP, combined
• In-market sales, or "IMS," is defined as sales to the retail channel, depending on the market and distribution model
• "Total shipment volume" is defined as the combined total of cigarette shipment volume and heated tobacco unit shipment volume
• Following the acquisitions of Fertin Pharma A/S, OtiTopic, Inc. and Vectura Group plc., PMI added the "Other" category in the third quarter of
2021. Business operations for the Other category are evaluated separately from the geographical operating segments
• "RBH" refers to PMI’s Canadian subsidiary, Rothmans, Benson & Hedges Inc.
• The Companies’ Creditors Arrangement Act (CCAA) is a Canadian federal law that permits a Canadian business to restructure its affairs while
carrying on its business in the ordinary course
34
-- 17 of 26 --
Glossary: General Terms (cont.)
• "EU" is defined as the European Union Region
• "EE" is defined as the Eastern Europe Region
• "ME&A" is defined as the Middle East & Africa Region and includes PMI's duty free business
• "S&SA" is defined as the South & Southeast Asia Region
• "EA&A" is defined as the East Asia & Australia Region
• “AMCS” is defined as the Americas Region. It refers to the former Latin America & Canada segment, which was renamed as the Americas
segment as of the third quarter of 2021. References to "Americas" may, in defined instances, exclude the U.S.
• Following the deconsolidation of PMI's Canadian subsidiary, Rothmans, Benson & Hedges, Inc. (RBH), PMI will continue to report the volume of
brands sold by RBH for which other PMI subsidiaries are the trademark owner. These include HEETS, Next, Philip Morris and Rooftop
• From time to time, PMI’s shipment volumes are subject to the impact of distributor inventory movements, and estimated total industry/market
volumes are subject to the impact of inventory movements in various trade channels that include estimated trade inventory movements of
PMI’s competitors arising from market-specific factors that significantly distort reported volume disclosures. Such factors may include changes
to the manufacturing supply chain, shipment methods, consumer demand, timing of excise tax increases or other influences that may affect the
timing of sales to customers. In such instances, in addition to reviewing PMI shipment volumes and certain estimated total industry/market
volumes on a reported basis, management reviews these measures on an adjusted basis that excludes the impact of distributor and/or estimated
trade inventory movements. Management also believes that disclosing PMI shipment volumes and estimated total industry/market volumes in
such circumstances on a basis that excludes the impact of distributor and/or estimated trade inventory movements, such as on an IMS basis,
improves the comparability of performance and trends for these measures over different reporting periods
• "ESG" stands for environmental, social, and governance
• "Illicit trade" refers to domestic non-tax paid products
• "SoM" stands for share of market
35
Glossary: Financial Terms
• Net revenues related to combustible products refer to the operating revenues generated from the sale of these products, including shipping and handling
charges billed to customers, net of sales and promotion incentives, and excise taxes. PMI recognizes revenue when control is transferred to the customer,
typically either upon shipment or delivery of goods
• Net revenues related to RRPs represent the sale of heated tobacco units, heat-not-burn devices and related accessories, and other nicotine-containing
products, primarily e-vapor and oral nicotine products, including shipping and handling charges billed to customers, net of sales and promotion incentives,
and excise taxes. PMI recognizes revenue when control is transferred to the customer, typically either upon shipment or delivery of goods
• Net revenues in the Other category primarily consist of operating revenues generated from the sale of inhaled therapeutics, and oral and intra-oral delivery
systems, that are included in the operating results of PMI’s new Wellness and Healthcare business, Vectura Fertin Pharma
• Adjusted net revenues exclude the impact related to the Saudi Arabia customs assessments
• “COGS“ stands for Cost Of Goods Sold
• "SG&A" stands for selling, general & administrative
• "Adjusted Operating Income (OI) Margin" is calculated as adjusted OI, divided by adjusted net revenues
• "Net debt" is defined as total debt, less cash and cash equivalents
• Growth rates presented on an organic basis for consolidated financial results reflect currency-neutral underlying results
• Management reviews net revenues, operating income, operating income margin, operating cash flow and earnings per share, or "EPS," on an adjusted basis,
which may exclude the impact of currency and other items such as acquisitions, asset impairment and exit costs, tax items and other special items.
Currency-neutral and organic growth rates reflect the way management views underlying performance for these measures. PMI believes that such
measures provide useful insight into underlying business trends and results. Management reviews these measures because they exclude changes in
currency exchange rates and other factors that may distort underlying business trends, thereby improving the comparability of PMI’s business performance
between reporting periods. Furthermore, PMI uses several of these measures in its management compensation program to promote internal fairness and a
disciplined assessment of performance against company targets. PMI discloses these measures to enable investors to view the business through the eyes of
management
• "Fair value adjustment for equity security investments" reflects the adjustment resulting from share price movements in passive investments for publicly
traded entities that are not controlled or influenced by PMI. Under U.S. GAAP, such adjustments are required, since January 1, 2018, to be reflected directly
in the income statement
36
-- 18 of 26 --
Glossary: Reduced-Risk Products
• Reduced-risk products (“RRPs”) is the term PMI uses to refer to products that present, are likely to present, or have the potential to
present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of
development, scientific assessment and commercialization. PMI's RRPs are smoke-free products that contain and/or generate far lower
quantities of harmful and potentially harmful constituents than found in cigarette smoke
• "Aerosol" refers to a gaseous suspension of fine solid particles and/or liquid droplets
• "Combustion" is the process of burning a substance in oxygen, producing heat and often light
• "Smoke" is a visible suspension of solid particles, liquid droplets and gases in air, emitted when a material burns
• "Heated tobacco units," or "HTUs," is the term PMI uses to refer to heated tobacco consumables, which include the company's HEETS,
HEETS Creations, HEETS Dimensions, HEETS Marlboro and HEETS FROM MARLBORO (defined collectively as HEETS), Marlboro Dimensions,
Marlboro HeatSticks, Parliament HeatSticks and TEREA, as well as the KT&G-licensed brands, Fiit and Miix (outside of South Korea)
• IQOS heat-not-burn devices are precisely controlled heating devices into which a specially designed and proprietary tobacco units are
inserted and heated to generate an aerosol
• "PMI heat-not-burn products" include licensed KT&G heat-not-burn products
• "PMI HTUs" include licensed KT&G HTUs
• HTU "offtake volume" represents the estimated retail offtake of HTUs based on a selection of sales channels that vary by market, but
notably include retail points of sale and e-commerce platforms
• HTU "offtake share" represents the estimated retail offtake volume of HTUs divided by the sum of estimated total offtake volume for
cigarettes and HTUs
• Market share for HTUs is defined as the total sales volume for HTUs as a percentage of the total estimated sales volume for cigarettes and
HTUs
37
Glossary: Reduced-Risk Products (cont.)
• "Total IQOS users" is defined as the estimated number of Legal Age (minimum 18 years) users of PMI heat-not-burn products, for which PMI
HTUs represented at least a portion of their daily tobacco consumption over the past seven days
The estimated number of adults who have "switched to IQOS and stopped smoking" reflects:
⎼ for markets where there are no heat-not-burn products other than PMI heat-not-burn products: daily individual consumption of PMI HTUs represents
the totality of their daily tobacco consumption in the past seven days
⎼ for markets where PMI heat-not-burn products are among other heat-not-burn products: daily individual consumption of HTUs represents the totality
of their daily tobacco consumption in the past seven days, of which at least 70% is PMI HTUs.
Note: The above IQOS user metrics reflect PMI estimates, which are based on consumer claims and sample-based statistical assessments with
an average margin of error of +/-5% at a 95% Confidence Interval in key volume markets. The accuracy and reliability of IQOS user metrics may
vary based on individual market maturity and availability of information
As of December 2020, PMI heat-not-burn products and HTUs include licensed KT&G heat-not-burn products and HTUs, respectively
• "FDA" stands for the U.S. Food & Drug Administration
• "MRTP" stands for Modified Risk Tobacco Product, the term used by the U.S. FDA to refer to RRPs
• "MRTP application" stands for Modified Risk Tobacco Product application under section 911 of the FD&C Act
• "PMTA" stands for Premarket Tobacco Application under section 910 of the FD&C Act
• "Acquisition" refers to our efforts to switch LAS from smoking cigarettes to RRPs or to switch LAU from competing smoke-free products to
PMI’s RRPs
• "Retention" refers to our efforts to deter LAU from going back to smoking cigarettes or from choosing a competing smoke-free product instead
of a PMI RRP
38
-- 19 of 26 --
EU Region: HTU SoM Performance in Select Markets
Note: Select markets where HTU share is ≥ 1%. Sales volume of PMI HTUs as a percentage of the total industry sales volume for cigarettes and HTUs
Source: PMI Financials or estimates 39
Q1, 2022
Growth
vs. PY Q1, 2022
Growth
vs. PY Q1, 2022
Growth
vs. PY
Croatia 6.7% +0.6pp Italy 14.8% +3.5pp Romania 5.7% +1.7pp
Czech
Republic 12.5 (1.1) Latvia 10.4 +1.1 Slovak
Republic 14.4 +1.6
Germany 5.9 +2.3 Lithuania 26.5 +2.5 Slovenia 10.3 +3.3
Greece 17.2 +2.2 Poland 7.6 +2.2 Switzerland 9.0 +3.5
Hungary 25.6 +9.0 Portugal 15.3 +3.2 UK 2.6 +0.6
(1) Reflects the adjustment resulting from share price movements in PMI's investments in India and Sri Lanka, which are publicly traded entities that are not controlled or influenced by PMI
Source: PMI Financials or estimates
2022
Forecast 2021 Growth
Reported Diluted EPS $5.39 – $5.50 $5.83
- Asset impairment and exit costs – 0.12
- Charges related to the war in Ukraine 0.03 –
- Saudi Arabia customs assessments – 0.14
- Fair value adjustment for equity security investments (1) 0.03 –
- Asset acquisition cost – 0.03
- Equity investee ownership dilution – (0.04)
Adjusted Diluted EPS $5.45 – $5.56 $6.08
- Less: Net Earnings attributable to Russia and Ukraine 0.10 0.60
Pro Forma Adjusted Diluted EPS $5.35 – $5.46 $5.48
- Less: Pro Forma Currency (0.63)
Adjusted Diluted EPS, excluding currency $5.98 – $6.09 $5.48 9% – 11%
2022: EPS Guidance
($/share)
40
Full-Year
-- 20 of 26 --
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
41
Reconciliation of Reported Diluted EPS to Reported Diluted EPS, excluding Currency,
and Reconciliation of Reported Diluted EPS to Adjusted Diluted EPS, excluding Currency
(Unaudited)
Quarters Ended March 31,
2022 2021 % Change
Reported Diluted EPS $ 1.50 $ 1.55 (3.2)%
Less: Currency (0.23)
Reported Diluted EPS, excluding Currency $ 1.73 $ 1.55 11.6%
Quarters Ended March 31, Year Ended
2022 2021 % Change 2021
Reported Diluted EPS $ 1.50 $ 1.55 (3.2)% $ 5.83
Asset impairment and exit costs - 0.02 0.12
Charges related to the Russia-Ukraine conflict 0.03 - -
Asset acquisition cost - - 0.03
Equity investee ownership dilution - - (0.04)
Saudi Arabia customs assessments - - 0.14
Fair value adjustment for equity security investments 0.03 - -
Tax items - - -
Adjusted Diluted EPS $ 1.56 $ 1.57 (0.6)% $ 6.08
Less: Currency (0.23)
Adjusted Diluted EPS, excluding Currency $ 1.79 $ 1.57 14.0%
42
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Net Revenues by Product Category and Adjustments of Net Revenues for the Impact of Currency and Acquisitions
($ in millions) / (Unaudited)
Note: Sum of product categories or Regions might not foot to Total PMI due to roundings. “-“ indicates amounts between -$0.5 million and +$0.5 million
Currency
Net
Revenues
excluding
Currency
Acquisitions
Net
Revenues
excluding
Currency &
Acquisitions
Quarters Ended
March 31,
Net
Revenues Total Excluding
Currency
Excluding
Currency &
Acquisitions
2022 Reduced-Risk Products 2021 % Change
$ 1,202 $ (82) $ 1,284 $ 4 $ 1,281 European Union $ 959 25.4% 34.0% 33.6%
270 (26) 295 - 295 Eastern Europe 304 (11.4)% (3.0)% (3.0)%
62 (1) 63 - 63 Middle East & Africa 21 +100% +100% +100%
5 - 5 - 5 South & Southeast Asia 2 +100% +100% +100%
803 (66) 869 - 869 East Asia & Australia 824 (2.5)% 5.5% 5.5%
8 - 8 - 8 Americas 12 (35.3)% (32.5)% (32.5)%
$ 2,350 $ (175) $ 2,525 $ 4 $ 2,521 Total RRPs $ 2,122 10.7% 19.0% 18.8%
2022 Other 2021 % Change
$ 66 $ - $ 66 $ 66 $ - Other $ - - - -
2022 PMI 2021 % Change
$ 3,012 $ (206) $ 3,218 $ 4 $ 3,214 European Union $ 2,909 3.5% 10.6% 10.5%
726 (72) 798 - 798 Eastern Europe 796 (8.8)% 0.3% 0.3%
991 (149) 1,140 - 1,140 Middle East & Africa 801 23.7% 42.3% 42.3%
1,123 (44) 1,167 - 1,167 South & Southeast Asia 1,173 (4.3)% (0.5)% (0.5)%
1,404 (106) 1,510 - 1,510 East Asia & Australia 1,472 (4.6)% 2.6% 2.6%
424 (13) 437 - 437 Americas 434 (2.3)% 0.7% 0.7%
66 - 66 66 - Other - - - -
$ 7,746 $ (590) $ 8,336 $ 70 $ 8,266 Total PMI $ 7,585 2.1% 9.9% 9.0%
Net
Revenues
-- 21 of 26 --
43
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Net Revenues to Adjusted Net Revenues, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
Net
Revenues
Adjusted
Net
Revenues
Currency
Adjusted
Net
Revenues
excluding
Currency
Acqui-
sitions
Adjusted Net
Revenues
excluding
Currency
& Acqui-
sitions
Net
Revenues
Adjusted
Net
Revenues
Total Excluding
Currency
Excluding
Currency
& Acqui-
sitions
2022 2021
$ 3,012 $ - $ 3,012 $ (206) $ 3,218 $ 4 $ 3,214 European Union $ 2,909 $ - $ 2,909 3.5% 10.6% 10.5%
726 - 726 (72) 798 - 798 Eastern Europe 796 - 796 (8.8)% 0.3% 0.3%
991 - 991 (149) 1,140 - 1,140 Middle East & Africa 801 - 801 23.7% 42.3% 42.3%
1,123 - 1,123 (44) 1,167 - 1,167 South & Southeast Asia 1,173 - 1,173 (4.3)% (0.5)% (0.5)%
1,404 - 1,404 (106) 1,510 - 1,510 East Asia & Australia 1,472 - 1,472 (4.6)% 2.6% 2.6%
424 - 424 (13) 437 - 437 Americas 434 - 434 (2.3)% 0.7% 0.7%
66 - 66 - 66 66 - Other - - - - - -
$ 7,746 $ - $ 7,746 $ (590) $ 8,336 $ 70 $ 8,266 Total PMI $ 7,585 $ - $ 7,585 2.1% 9.9% 9.0%
Special
Items
Special
Items
Quarters Ended
March 31, % Change
44
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Operating Income to Adjusted Operating Income, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
(1) Represents charges related to the war in Ukraine
Operating
Income
Adjusted
Operating
Income
Currency
Adjusted
Operating
Income
excluding
Currency
Acqui-
sitions
Adjusted
Operating
Income
excluding
Currency
& Acqui-
sitions
Operating
Income
Adjusted
Operating
Income
Total Excluding
Currency
Excluding
Currency
& Acqui-
sitions
2022 2021
$ 1,527 $ - $ 1,527 $ (145) $ 1,672 $ (2) $ 1,674 European Union $ 1,490 $ (9) $ 1,499 1.9% 11.5% 11.7%
144 (42) (1)
186 (60) 246 - 246 Eastern Europe 261 (2) 263 (29.3)% (6.5)% (6.5)%
521 - 521 (115) 636 - 636 Middle East & Africa 335 (2) 337 54.6% 88.7% 88.7%
445 - 445 (25) 470 - 470 South & Southeast Asia 529 (3) 532 (16.4)% (11.7)% (11.7)%
571 - 571 (68) 639 - 639 East Asia & Australia 695 (31) 726 (21.3)% (12.0)% (12.0)%
121 - 121 (2) 123 - 123 Americas 134 (1) 135 (10.4)% (8.9)% (8.9)%
(31) - (31) - (31) (24) (7) Other - - - - - -
$ 3,298 $ (42) $ 3,340 $ (415) $ 3,755 $ (26) $ 3,781 Total PMI $ 3,444 $ (48) $ 3,492 (4.4)% 7.5% 8.3%
Asset
Impairment
& Exit Costs
and Others
% Change
Quarters Ended
March 31,
Asset
Impairment
& Exit Costs
-- 22 of 26 --
45
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
Reconciliation of Adjusted Operating Income Margin, excluding Currency and Acquisitions
($ in millions) / (Unaudited)
(1) For the calculation of Adjusted Operating Income and Adjusted Operating Income excluding currency and acquisitions refer to slide 44
(2) For the calculation of Adjusted Net Revenues and Adjusted Net Revenues excluding currency and acquisitions refer to slide 43
Adjusted
Operating
Income
(1)
Adjusted
Net
Revenues
(2)
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
excluding
Currency
(1)
Adjusted
Net
Revenues
excluding
Currency
(2)
Adjusted
Operating
Income
Margin
excluding
Currency
Adjusted
Operating
Income
excluding
Currency &
Acqui-
sitions (1)
Adjusted
Net
Revenues
excluding
Currency &
Acqui-
sitions (2)
Adjusted
Operating
Income
Margin
excluding
Currency &
Acqui-
sitions
Adjusted
Operating
Income
(1)
Adjusted
Net
Revenues
(2)
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
Margin
Adjusted
Operating
Income
Margin
excluding
Currency
Adjusted
Operating
Income
Margin
excluding
Currency &
Acqui-
sitions
2022 2021 % Points Change
$ 1,527 $ 3,012 50.7% $ 1,672 $ 3,218 52.0% $ 1,674 $ 3,214 52.1% European Union $ 1,499 $ 2,909 51.5% (0.8) 0.5 0.6
186 726 25.6% 246 798 30.8% 246 798 30.8% Eastern Europe 263 796 33.0% (7.4) (2.2) (2.2)
521 991 52.6% 636 1,140 55.8% 636 1,140 55.8% Middle East & Africa 337 801 42.1% 10.5 13.7 13.7
445 1,123 39.6% 470 1,167 40.3% 470 1,167 40.3% South & Southeast Asia 532 1,173 45.4% (5.8) (5.1) (5.1)
571 1,404 40.7% 639 1,510 42.3% 639 1,510 42.3% East Asia & Australia 726 1,472 49.3% (8.6) (7.0) (7.0)
121 424 28.5% 123 437 28.1% 123 437 28.1% Americas 135 434 31.1% (2.6) (3.0) (3.0)
(31) 66 (47.0)% (31) 66 (47.0)% (7) - - Other - - - - - -
$ 3,340 $ 7,746 43.1% $ 3,755 $ 8,336 45.0% $ 3,781 $ 8,266 45.7% Total PMI $ 3,492 $ 7,585 46.0% (2.9) (1.0) (0.3)
Quarters Ended
March 31,
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
46
Adjustments for the Impact of Russia and Ukraine, excluding Currency
(Unaudited)
2022 2021 Currency
Variance
excluding
Currency
Adjusted Diluted EPS $ 1.56 $ 1.57 $ (0.23) 14.0%
Net Earnings attributable to Russia and Ukraine 0.10 0.13 (0.02)
Adjusted Diluted EPS, excluding Russia and Ukraine $ 1.46 $ 1.44 $ (0.21) 16.0%
Quarters Ended March 31,
(1) For the calculation of Adjusted diluted EPS, see slide 41
(1)
-- 23 of 26 --
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
47
PMI & EE Region - Adjustments for the Impact of Russia and Ukraine, excluding Currency and Acquisitions
(Unaudited)
(1) For the calculation of Adjusted Net Revenues, see slide 43
(2) For the calculation of Adjusted Operating Income, see slide 44
(3) Includes also impact of corporate expenses apportioned to Russia and Ukraine
2022 2021 Currency Acqui-
sitions
Variance
excluding
Currency
& Acqui-
sitions
PMI
Adjusted Net Revenues (1) $ 7,746 $ 7,585 $ (590) $ 70 9.0%
Net Revenues attributable to Russia and Ukraine 474 561 (63) -
Adjusted Net Revenues, ex. Russia and Ukraine $ 7,272 $ 7,024 $ (527) $ 70 10.0%
Adjusted Operating Income (2) $ 3,340 $ 3,492 $ (415) $ (26) 8.3%
Operating Income attributable to Russia and Ukraine 181 227 (38) -
Adjusted Operating Income, ex. Russia and Ukraine $ 3,159 $ 3,265 $ (377) $ (26) 9.1%
Adjusted Operating Income Margin 43.1% 46.0% (1.9)pp (0.7)pp (0.3)pp
Adjusted Operating Income margin attributable to Russia and Ukraine (0.3)pp (0.5)pp
Adjusted Operating Income Margin, ex. Russia and Ukraine 43.4% 46.5% (1.9)pp (0.8)pp (0.4)pp
Eastern Europe
Adjusted Net Revenues (1) $ 726 $ 796 $ (72) $ - 0.3%
Net Revenues attributable to Russia and Ukraine 474 561 (63) -
Adjusted Net Revenues, ex. Russia and Ukraine $ 252 $ 235 $ (9) $ - 11.1%
Adjusted Operating Income (2) $ 186 $ 263 $ (60) $ - (6.5)%
Operating Income attributable to Russia and Ukraine 181 227 (38) -
Corporate expenses apportioned to Russia and Ukraine (61) (50) 3 -
Adjusted Operating Income, ex. Russia and Ukraine $ 66 $ 86 $ (25) $ - 6.1%
Adjusted Operating Income Margin 25.6% 33.0% (5.2)pp - (2.2)pp
Adjusted Operating Income margin attributable to Russia and Ukraine (3) (0.6)pp (3.6)pp
Adjusted Operating Income Margin, ex. Russia and Ukraine 26.2% 36.6% (8.8)pp - (1.6)pp
Quarters Ended March 31,
Year Ended December 31,
2022 2021 Currency Acqui-
sitions
Variance
excluding
Currency &
Acquisitions
2021
Combustible Products
Adjusted Net Revenues $ 5,330 $ 5,463 $ (415) $ - 5.2% $ 22,436
Net Revenues attributable to Russia and Ukraine 269 308 (41) - 1,399
Pro Forma Adjusted Net Revenues $ 5,062 $ 5,155 $ (374) $ - 5.5% $ 21,037
Reduced-Risk Products
Adjusted Net Revenues $ 2,350 $ 2,122 $ (175) $ 4 18.8% $ 9,115
Net Revenues attributable to Russia and Ukraine 205 253 (23) - 1,072
Pro Forma Adjusted Net Revenues $ 2,145 $ 1,869 $ (153) $ 4 22.8% $ 8,042
Other
Adjusted Net Revenues $ 66 $ - $ - $ 66 +100% $ 101
Net Revenues attributable to Russia and Ukraine - - - - -
Pro Forma Adjusted Net Revenues $ 66 $ - $ - $ 66 +100% $ 101
PMI
Adjusted Net Revenues $ 7,746 $ 7,585 $ (590) $ 70 9.0% $ 31,651
Net Revenues attributable to Russia and Ukraine 474 561 (63) - 2,471
Pro Forma Adjusted Net Revenues $ 7,272 $ 7,024 $ (527) $ 70 10.0% $ 29,180
Quarters Ended March 31,
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
48
Net Revenues by Product Category and Adjustments for the Impact of Russia and Ukraine
(Unaudited)
Note: For the calculation of Adjusted Net Revenues see slide 43. Sum of product categories might not foot to Total PMI due to roundings. "-" indicates amounts between -$0.5 million
and +$0.5 million
-- 24 of 26 --
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
49
PMI Shipment Volume Adjusted for the Impact of Russia and Ukraine
(Unaudited)
Note: Sum of product categories might not foot to total due to roundings
Year Ended December 31,
2022 2021 % Change 2021
Cigarettes
Shipment Volume 148,238 145,512 1.9% 624,875
Russia 10,772 12,101 52,499
Ukraine 2,211 2,359 10,669
Pro Forma Shipment Volume 135,255 131,052 3.2% 561,707
Heated Tobacco Units
Shipment Volume 24,819 21,734 14.2% 94,976
Russia 3,359 3,582 16,309
Ukraine 1,383 1,193 5,168
Pro Forma Shipment Volume 20,076 16,959 18.4% 73,499
PMI
Shipment Volume 173,057 167,246 3.5% 719,851
Russia 14,131 15,682 68,807
Ukraine 3,595 3,552 15,838
Pro Forma Shipment Volume 155,331 148,011 4.9% 635,206
Quarters Ended March 31,
PHILIP MORRIS INTERNATIONAL INC. and Subsidiaries
Reconciliation of Non-GAAP Measures
50
Reconciliation of Reported Diluted EPS to Pro Forma Adjusted Diluted EPS
(Unaudited)
Note: EPS is computed independently for each of the periods presented. Accordingly, the sum of the quarterly EPS amounts may not agree to the total for the year
Reported Diluted EPS $ 1.55 $ 1.39 $ 2.93 $ 1.55 $ 4.48 $ 1.34 $ 5.83
Asset impairment and exit costs 0.02 0.04 0.07 0.02 0.09 0.02 0.12
Asset acquisition cost - - - 0.03 0.03 - 0.03
Equity investee ownership dilution - - - (0.02) (0.02) (0.01) (0.04)
Saudi Arabia customs assessments - 0.14 0.14 - 0.14 - 0.14
Tax items - - - - - - -
Adjusted Diluted EPS $ 1.57 $ 1.57 $ 3.14 $ 1.58 $ 4.72 $ 1.35 $ 6.08
Net Earnings attributable to Russia & Ukraine 0.13 0.15 0.28 0.15 0.43 0.17 0.60
Pro Forma Adjusted Diluted EPS $ 1.44 $ 1.42 $ 2.86 $ 1.43 $ 4.29 $ 1.18 $ 5.48
Weighted-average shares for diluted EPS 1,560 1,560 1,560 1,560 1,560 1,557 1,559
December 31,
2021 2021 2021 2021 2021 2021 2021
March 31, June 30, June 30, September 30, September 30, December 31,
Quarter
Ended
Quarter
Ended
Six Months
Ended
Quarter
Ended
Nine Months
Ended
Quarter
Ended
Year
Ended
-- 25 of 26 --
Delivering a Smoke-Free Future
2022 First-Quarter Results
April 21, 2022
-- 26 of 26 --